Relationship between blood viscosity and no-reflow phenomenon in ST-segment elevation myocardial infarction performed

Arafat Yildirim1, Mehmet Kucukosmanoglu1, Nermin Y Koyunsever1

  • 1Department of Cardiology, University of Health Sciences - Adana Health Practice & Research Center, Adana, Turkey.

Insights

Increased whole-blood viscosity, measured by low shear rate (LSR) and high shear rate (HSR), is a significant predictor of no-reflow phenomenon development in ST-elevated myocardial infarction patients.

Area of Science:

  • Cardiology
  • Hematology
  • Biomedical Engineering

Background:

  • The no-reflow phenomenon is a critical complication following reperfusion therapy for ST-elevated myocardial infarction.
  • Understanding factors contributing to no-reflow is essential for improving patient outcomes.

Purpose of the Study:

  • To investigate the association between whole-blood viscosity and the development of the no-reflow phenomenon.
  • To identify specific viscosity parameters that predict no-reflow in ST-elevated myocardial infarction patients.

Main Methods:

  • A cohort of 217 patients with ST-elevated myocardial infarction was analyzed.
  • Whole-blood viscosity was assessed using hematocrit and total protein levels.
  • Low shear rate (LSR) and high shear rate (HSR) viscosity parameters were calculated.

Main Results:

  • Patients with ST-elevated myocardial infarction exhibited significantly higher average LSR and HSR values compared to controls.
  • Both HSR (OR: 4.957) and LSR (OR: 1.114) were identified as independent predictors for no-reflow development.
  • The statistical significance for both parameters was p < 0.001.

Conclusions:

  • Elevated whole-blood viscosity, specifically higher LSR and HSR, is an independent predictor of no-reflow phenomenon.
  • These findings suggest that blood viscosity could be a therapeutic target to mitigate no-reflow post-myocardial infarction.